- Prescribing Advice for GPs - https://www.prescriber.org.uk -

SMC Rejects Pregabalin for Nerve Pain

The Scottish Medicines Consortium has completed an appraisal following a re-submission for Lyrica (Pregabalin).

They have concluded that based on current data clinical and cost effectiveness has not been demonstrated for patients who fail to respond to current treatments.

Action: Continue using conventional therapies for the treatment of pain caused by peripheral damage to nerves. Do not use Pregabalin when other treatments fail.